Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class
Equity / Common Stock, $0.0001 par value
Total 13F shares
53,528,634
Total 13F value
$2,192,860,452
Holder snapshot 6 visible 7 signals
Share change
+15,680,042
Put/Call ratio
113%
SEC-reported price per share
$40.97
Number of holders
109
Value change
+$657,421,714
Number of buys
96
Open additional details 1 more signal available
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
168,432,200

Security key

92764N102

Report period

Q2 2020

Institutions

109

Top holders

10

VIR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2020 Previous quarter: Q1 2020 Vir Biotechnology, Inc. SEC filings Vir Biotechnology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership Top 5
SB INVESTMENT ADVISERS (UK) LTD 13%
Temasek Holdings (Private) Ltd 3.3%
ICONIQ Capital, LLC 2%
Alphabet Inc. 0.99%
Alaska Permanent Fund Corp 0.89%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
13%
$775,073,000
22,616,666 shares
 — 31 Mar 2020
Temasek Holdings (Private) Ltd
13F
Company
13F
3.3%
$188,485,000
5,499,999 shares
 — 31 Mar 2020
ICONIQ Capital, LLC
13F
Company
13F
2%
$114,233,000
3,333,333 shares
 — 31 Mar 2020
Alphabet Inc.
13F
Company
13F
0.99%
$57,117,000
1,666,666 shares
 — 31 Mar 2020
Alaska Permanent Fund Corp
13F
Company
13F
0.89%
$51,405,000
1,500,000 shares
 — 31 Mar 2020
Capital International Investors
13F
Company
13F
0.65%
$37,502,000
1,094,305 shares
 — 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
109
Shares
53,528,634
Rows available
109
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
61
Q2 2020 holders
109
Holder diff
48
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .